Literature DB >> 2393285

Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy.

G Otto1, J G Fox, P Y Wu, N S Taylor.   

Abstract

Colonization of the ferret stomach by Helicobacter mustelae has been suggested as a possible animal model for Helicobacter pylori-associated gastroduodenal disease of humans. Our study was designed to determine whether antimicrobial chemotherapy could eradicate H. mustelae from ferrets. Triple antimicrobial therapy combining amoxicillin, metronidazole, and bismuth subsalicylate was successful in eradicating the organism from 5 of 7 (71%) adult ferrets. Despite apparent in vitro susceptibility, neither chloramphenicol monotherapy nor a polytherapeutic regimen combining tetracycline, metronidazole, and bismuth subsalicylate proved effective in the eradication of H. mustelae. Several strains isolated after unsuccessful polytherapy showed markedly increased resistance to metronidazole. These preliminary findings are similar to results of H. pylori treatment trials with humans and suggest that the ferret may be a useful model for evaluating and comparing potential antimicrobial modalities for the eradication of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393285      PMCID: PMC171790          DOI: 10.1128/AAC.34.6.1232

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Treatment of proliferative colitis in ferrets.

Authors:  K L Krueger; J C Murphy; J G Fox
Journal:  J Am Vet Med Assoc       Date:  1989-05-15       Impact factor: 1.936

2.  Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.

Authors:  J C Mertens; W Dekker; E E Ligtvoet; P Blok
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

3.  Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).

Authors:  A Morris; P Brown; M R Ali; M Lane; R Palmer
Journal:  N Z Med J       Date:  1988-10-26

4.  Effects of yohimbine on bradycardia and duration of recumbency in ketamine/xylazine anesthetized ferrets.

Authors:  T J Sylvina; N G Berman; J G Fox
Journal:  Lab Anim Sci       Date:  1990-03

5.  Campylobacter pylori isolated from the stomach of the monkey, Macaca nemestrina.

Authors:  M A Bronsdon; F D Schoenknecht
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  The characterization and pathological significance of gastric Campylobacter-like organisms in the ferret: a model for chronic gastritis?

Authors:  D S Tompkins; J I Wyatt; B J Rathbone; A P West
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

7.  Campylobacter pylori gastritis: long term results of treatment with amoxycillin.

Authors:  G Oderda; D Dell'Olio; I Morra; N Ansaldi
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

8.  Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa.

Authors:  C A McNulty; J C Dent; G A Ford; S P Wilkinson
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

Review 9.  Gastric campylobacter-like organisms: their role in gastric disease of laboratory animals.

Authors:  J G Fox; A Lee
Journal:  Lab Anim Sci       Date:  1989-11

10.  Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.

Authors:  T J Borody; P Cole; S Noonan; A Morgan; J Lenne; L Hyland; S Brandl; E G Borody; L L George
Journal:  Med J Aust       Date:  1989-10-16       Impact factor: 7.738

View more
  14 in total

1.  Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo).

Authors:  J G Fox; G Otto; N S Taylor; W Rosenblad; J C Murphy
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori.

Authors:  M R Millar; J Pike
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Urease from a potentially pathogenic coccoid isolate: purification, characterization, and comparison to other microbial ureases.

Authors:  S G Lee; D H Calhoun
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Use of PCR and culture to detect Helicobacter pylori in naturally infected cats following triple antimicrobial therapy.

Authors:  S E Perkins; L L Yan; Z Shen; A Hayward; J C Murphy; J G Fox
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Helicobacter mustelae-associated gastric MALT lymphoma in ferrets.

Authors:  S E Erdman; P Correa; L A Coleman; M D Schrenzel; X Li; J G Fox
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

6.  Inability of an isogenic urease-negative mutant stain of Helicobacter mustelae to colonize the ferret stomach.

Authors:  K A Andrutis; J G Fox; D B Schauer; R P Marini; J C Murphy; L Yan; J V Solnick
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Biochemical studies of Helicobacter mustelae fatty acid composition and flagella.

Authors:  S Suerbaum; G Geis; C Josenhans; W Opferkuch
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Development of a 14C-urea breath test in ferrets colonised with Helicobacter mustelae: effects of treatment with bismuth, antibiotics, and urease inhibitors.

Authors:  A A McColm; J A Bagshaw; C F O'Malley
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

9.  Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; L Yan; B Shames
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

10.  Animal and public health implications of gastric colonization of cats by Helicobacter-like organisms.

Authors:  G Otto; S H Hazell; J G Fox; C R Howlett; J C Murphy; J L O'Rourke; A Lee
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.